.
  • NIFTY 25,875.55 -85.00 (-0.33%)
  • SENSEX 84,827.96 -274.73 (-0.32%)
 
BSE
NSE

Tuesday, December 09, 2025 , BSE Sensex : 84,827.96 84,827.96(-0.32%) , Adani Ports : 1,493.00 1,493.00(0.89%) , Asian Paints : 2,802.85 2,802.85(-4.20%) , Axis Bank : 1,279.50 1,279.50(0.46%) , Bajaj Finance : 1,020.00 1,020.00(-0.61%) , Bajaj Finserv : 2,073.90 2,073.90(0.73%) , Bharat Electron : 390.85 390.85(1.13%) , Bharti Airtel : 2,087.00 2,087.00(0.05%) , Eternal Ltd : 289.10 289.10(1.35%) , HCL Technologies : 1,670.15 1,670.15(-1.06%) , HDFC Bank : 998.90 998.90(-0.42%) , Hind. Unilever : 2,321.10 2,321.10(0.29%) , ICICI Bank : 1,375.45 1,375.45(-1.00%) , Infosys : 1,596.80 1,596.80(-0.82%) , ITC : 403.90 403.90(0.44%) , Kotak Mah. Bank : 2,124.50 2,124.50(-0.33%) , Larsen & Toubro : 4,007.30 4,007.30(0.29%) , M & M : 3,625.45 3,625.45(-1.51%) , Maruti Suzuki : 16,151.35 16,151.35(-0.19%) , NTPC : 320.00 320.00(0.17%) , Power Grid Corpn : 264.55 264.55(-0.25%) , Reliance Industr : 1,533.15 1,533.15(-0.61%) , SBI : 962.45 962.45(0.66%) , Sun Pharma.Inds. : 1,790.00 1,790.00(-0.30%) , Tata Motors PVeh : 346.25 346.25(-0.53%) , Tata Steel : 161.95 161.95(-0.92%) , TCS : 3,205.90 3,205.90(-0.99%) , Tech Mahindra : 1,566.20 1,566.20(-1.61%) , Titan Company : 3,870.00 3,870.00(2.79%) , Trent : 4,088.40 4,088.40(-0.06%) , UltraTech Cem. : 11,493.90 11,493.90(-0.33%) ,

Nifty 50 : 25,875.55 -85.00(-0.33%) , Adani Enterp. : 2,248.80 32.60(1.47%) , Adani Ports : 1,492.90 12.40(0.84%) , Apollo Hospitals : 7,101.00 5.00(0.07%) , Asian Paints : 2,808.80 -119.50(-4.08%) , Axis Bank : 1,278.50 4.70(0.37%) , Bajaj Auto : 8,975.50 -50.50(-0.56%) , Bajaj Finance : 1,020.10 -6.30(-0.61%) , Bajaj Finserv : 2,072.30 13.10(0.64%) , Bharat Electron : 390.50 4.10(1.06%) , Bharti Airtel : 2,087.50 1.30(0.06%) , Cipla : 1,496.90 -0.70(-0.05%) , Coal India : 379.90 2.55(0.68%) , Dr Reddy's Labs : 1,256.20 -10.30(-0.81%) , Eicher Motors : 7,175.50 33.50(0.47%) , Eternal Ltd : 289.25 4.00(1.40%) , Grasim Inds : 2,769.60 25.40(0.93%) , HCL Technologies : 1,669.90 -18.70(-1.11%) , HDFC Bank : 998.80 -4.30(-0.43%) , HDFC Life Insur. : 758.50 -5.55(-0.73%) , Hind. Unilever : 2,320.00 6.00(0.26%) , Hindalco Inds. : 813.55 -5.90(-0.72%) , ICICI Bank : 1,375.30 -14.30(-1.03%) , Infosys : 1,596.90 -13.90(-0.86%) , Interglobe Aviat : 4,882.50 -41.00(-0.83%) , ITC : 403.85 1.55(0.39%) , Jio Financial : 295.45 -1.75(-0.59%) , JSW Steel : 1,111.90 -7.20(-0.64%) , Kotak Mah. Bank : 2,124.30 -7.30(-0.34%) , Larsen & Toubro : 4,008.60 11.90(0.30%) , M & M : 3,632.00 -49.70(-1.35%) , Maruti Suzuki : 16,152.00 -35.00(-0.22%) , Max Healthcare : 1,068.90 -10.50(-0.97%) , Nestle India : 1,219.20 4.40(0.36%) , NTPC : 320.15 0.65(0.20%) , O N G C : 239.39 0.87(0.36%) , Power Grid Corpn : 264.65 -0.55(-0.21%) , Reliance Industr : 1,531.20 -11.80(-0.76%) , SBI : 961.10 4.70(0.49%) , SBI Life Insuran : 1,999.70 -21.00(-1.04%) , Shriram Finance : 842.70 8.45(1.01%) , Sun Pharma.Inds. : 1,795.10 -1.10(-0.06%) , Tata Consumer : 1,144.70 -1.10(-0.10%) , Tata Motors PVeh : 346.50 -1.80(-0.52%) , Tata Steel : 161.79 -1.68(-1.03%) , TCS : 3,199.00 -37.50(-1.16%) , Tech Mahindra : 1,566.50 -25.30(-1.59%) , Titan Company : 3,867.60 100.60(2.67%) , Trent : 4,089.10 -1.40(-0.03%) , UltraTech Cem. : 11,493.00 -47.00(-0.41%) , Wipro : 258.32 -3.06(-1.17%) , Tuesday, December 09, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
05-Dec-2025     10:05
Lupin receives USFDA tentative nod for Siponimod tablets
The product is a generic equivalent of Novartis Pharmaceuticals' Mayzent Tablets and is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.

Lupin said the tablets will be manufactured at its Pithampur facility in India. According to IQVIA MAT October 2025 data, Siponimod Tablets (reference listed drug Mayzent) recorded annual U.S. sales of USD 195 million.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

Lupin reported a 73.33% surge in consolidated net profit to Rs 1,477.92 crore in Q2 FY26 as against Rs 852.63 crore posted in Q2 FY25. Revenue from operations jumped 24.27% year-on-year to Rs 6,831.43 crore in the quarter ended 30 September 2025.

The counter shed 0.21% to Rs 2,087.55 on the BSE.

Powered by Capital Market - Live News